Aytu Biopharma AYTU
NASDAQ AYTU
$2.27 -0.09 (-3.81%)
As of: Aug 20, 2026 · 3:47 PM EDT

Aytu Biopharma (AYTU) Debt Ratio (2011 - 2026)

Aytu Biopharma (AYTU) posted quarterly Debt Ratio of 0.1 for Q1 2026, up 11.34% year-over-year from 0.09 in Q1 2025, and down 34.68% quarter-over-quarter from 0.16 in Q4 2025.

Aytu Biopharma (AYTU) Debt Ratio (2011 - 2026) Analysis & Trends

Aytu Biopharma (AYTU) has reported Debt Ratio for 15 consecutive years, with 0.1 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Debt Ratio rose 11.34% year-over-year to 0.1; the TTM figure through Mar 2026 stood at 0.1 (up 11.34% YoY), while the FY2025 annual figure was 0.16, up 43.01% from the prior year.
  • Debt Ratio eased to 0.1 in Q1 2026 per AYTU's latest filing, from 0.16 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.16 in Q2 2025 and bottomed at 0.01 in Q1 2024.
  • Historically, Debt Ratio has averaged 0.11 across 5 years, with a median of 0.11 in 2023.
  • On a YoY basis, Debt Ratio climbed as much as 1633.41% in 2022 and fell as far as 99.92% in 2022.
  • Aytu Biopharma's Debt Ratio stood at 0.1 in 2022, then grew by 17.94% to 0.12 in 2023, then fell by 16.46% to 0.1 in 2024, then surged by 53.47% to 0.16 in 2025, then slumped by 34.68% to 0.1 in 2026.
  • Business Quant data shows AYTU's Debt Ratio at 0.1 in Q1 2026, 0.16 in Q4 2025, and 0.1 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Haleon 43.85 Bn 42.88 Bn - -0.13
2 Teva Pharmaceutical Industries 43.02 Bn 39.37 Bn 2.15 Bn 0.42
3 Zoetis 31.47 Bn 29.79 Bn 1.05 Bn 0.60
4 Takeda Pharmaceutical 28.59 Bn 22.79 Bn 5.10 Bn 0.32
5 United Therapeutics 22.20 Bn 19.53 Bn 683.80 Mn -
6 Viatris 18.76 Bn 17.87 Bn 1.46 Bn 0.38
7 Neurocrine Biosciences 15.45 Bn 15.06 Bn 935.80 Mn -
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn 0.29
9 Dr Reddys Laboratories 10.10 Bn 9.94 Bn - 0.12
10 Aytu Biopharma 23.86 Mn -2.85 Mn 7.60 Mn 0.18

Historic Data

Download Data
DateValue
Mar 31, 2026 0.10
Dec 31, 2025 0.16
Sep 30, 2025 0.10
Jun 30, 2025 0.16
Mar 31, 2025 0.09
Dec 31, 2024 0.10
Sep 30, 2024 0.13
Jun 30, 2024 0.11
Mar 31, 2024 0.01
Dec 31, 2023 0.12
Sep 30, 2023 0.11
Jun 30, 2023 0.12
Mar 31, 2023 0.10
Dec 31, 2022 0.10
Sep 30, 2022 0.15
Jun 30, 2022 0.13
Mar 31, 2022 0.08
Dec 31, 2021 0.01
Sep 30, 2021 0.02
Jun 30, 2021 0.06